Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citalopram Added to Methylphenidate in Youth With Severe Mood Dysregulation
NCT00794040Phase 2Completed
- Sponsor
- National Institute of Mental Health
- Start
- Nov 2008
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of citalopram in disruptive mood dysregulation disorder (DMDD), sponsored by National Institute of Mental Health. Started Nov 2008; status: completed.
02
Drugs
citalopram
03
Conditions
disruptive mood dysregulation disorder (DMDD)
Beyond the preview
Go deeper on NCT00794040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00794040.